Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACOX in Advanced HCC
NCT02089633Phase 2Completed
- Sponsor
- Bio-Cancer Treatment International Limited
- Start
- Apr 2014
- Primary completion
- Sep 2016
- Modality
- PEGylated Peptides, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of arginase-1 in hepatocellular carcinoma (HCC), sponsored by Bio-Cancer Treatment International Limited. Started Apr 2014; status: completed.
02
Drugs
arginase-1
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02089633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089633.